These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 20625276

  • 1. Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences.
    Anzueto A.
    Am J Med Sci; 2010 Oct; 340(4):309-18. PubMed ID: 20625276
    [Abstract] [Full Text] [Related]

  • 2. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
    Fromer L, Barnes T, Garvey C, Ortiz G, Saver DF, Yawn B.
    Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA.
    Pulm Pharmacol Ther; 2008 Sep; 21(3):540-50. PubMed ID: 18280761
    [Abstract] [Full Text] [Related]

  • 5. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 6. [Long-term treatment strategy in chronic obstructive pulmonary disease: how to change the course of the disease].
    Devillier P, Salvator H, Roche N, Grassin-Delyle S, Naline E, Dorocant S, Neveu H.
    Presse Med; 2014 Dec; 43(12 Pt 1):1368-80. PubMed ID: 25455634
    [Abstract] [Full Text] [Related]

  • 7. Long-acting muscarinic antagonists for the prevention of exacerbations of chronic obstructive pulmonary disease.
    Jones PW.
    Ther Adv Respir Dis; 2015 Jun; 9(3):84-96. PubMed ID: 25801643
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP.
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Guideline for the management of chronic obstructive pulmonary disease--2011 update.
    Abdool-Gaffar MS, Ambaram A, Ainslie GM, Bolliger CT, Feldman C, Geffen L, Irusen EM, Joubert J, Lalloo UG, Mabaso TT, Nyamande K, O'Brien J, Otto W, Raine R, Richards G, Smith C, Stickells D, Venter A, Visser S, Wong M, COPD Working Group.
    S Afr Med J; 2011 Jan; 101(1 Pt 2):63-73. PubMed ID: 21526617
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Common lung conditions: chronic obstructive pulmonary disease.
    Delzell JE.
    FP Essent; 2013 Jun; 409():23-31. PubMed ID: 23767419
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA.
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
    Dixit D, Bridgeman MB, Andrews LB, Narayanan N, Radbel J, Parikh A, Sunderram J.
    Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
    [Abstract] [Full Text] [Related]

  • 18. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K, Janson C, Lisspers K, Jørgensen L, Stratelis G, Telg G, Ställberg B, Johansson G.
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [Abstract] [Full Text] [Related]

  • 19. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L, Forget A, Ramachandran S.
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.